Fluzoparib & Abiraterone in the preSurgery Treatment of Prostate Cancer:

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05161572` - Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer	Phase 2
Not yet recruiting	`NCT05996484` - Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma	Phase 2
Not yet recruiting	`NCT04520737` - Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver Metastases	N/A
Recruiting	`NCT06138496` - Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC	Phase 2
Not yet recruiting	`NCT05983094` - Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer	Phase 2
Terminated	`NCT04440982` - Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients	Phase 2
Recruiting	`NCT04028375` - Study of CT and MR in the Gastric Cancer
Active, not recruiting	`NCT03192735` - Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer	Phase 2
Recruiting	`NCT04588987` - Neoadjuvant Carilizumab and Apatinib for Recurrent High-Grade Glioma	Phase 2
Not yet recruiting	`NCT05993858` - Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC	Phase 2
Active, not recruiting	`NCT04666090` - Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma	Phase 2
Recruiting	`NCT04848454` - Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy	Phase 2
Recruiting	`NCT04062058` - A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer	Phase 2
Recruiting	`NCT06124378` - Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer	Phase 2
Not yet recruiting	`NCT06125223` - PABLIXIMAB as Neoadjuvant Therapy for Head and Neck Squamous-cell Carcinoma
Recruiting	`NCT05371197` - Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer	Phase 2
Recruiting	`NCT06212440` - Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy	N/A
Completed	`NCT03178032` - Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine Gliomas	Phase 1
Recruiting	`NCT02769104` - Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer	Phase 3
Active, not recruiting	`NCT04986306` - The Validation of Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer Patients

NCT number	NCT05223582
Study type	Interventional
Source	Fudan University
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	May 1, 2021
Completion date	December 2023

Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms